tstbio provides advanced SAW Open Platform Services and has been partnering with industry leaders since 2021 by offering its innovative SAW Platform. Headquartered in Taiwan, tstbio was established in 2018 as a biomedical electronics spin-off company from Tai-Saw Technology Co., Ltd. 

Combining the core technology of Surface Acoustic Waves (SAW) from TST with the expertise of its long-term strategic partner, Japan Radio Co., Ltd. (JRC), tstbio has developed the groundbreaking “iProtin” platform. This POCT (point-of-care testing) solution is designed to deliver simple, reliable, and robust biosensor technology for both home and clinical applications.

In addition to the iProtin platform, tstbio offers a diverse portfolio of biomedical devices to address the growing global demand for health management solutions. Committed to innovation and excellence, tstbio continues to redefine the possibilities in biomedical electronics, contributing to a healthier, more connected future for communities worldwide.